SCHEMBL8619214

SCHEMBL8619214

CCC(C)(C)Cc1ccc(-c2cc(C(=O)NC(=N)N)c3ccccc3n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
NPC1 O15118 3/20 0.52
RAB9A P51151 3/20 0.52
ALDH1A1 P00352 3/20 0.52
MITF O75030 1/20 0.52
PKM P14618 1/20 0.52
LMNA P02545 2/20 0.51
TACR3 P29371 5/20 0.50
TSHR P16473 1/20 0.50
HPGD P15428 3/20 0.49
ACACB O00763 1/20 0.49
ACACA Q13085 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
DHODH Q02127 2/20 0.49
POLB P06746 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8616019 0.86 KDM4E (0.55) KDM4ESMN1; SMN2MEN1KMT2ANPC1
SCHEMBL8615804 0.83 KDM4E (0.64) KDM4ESMN1; SMN2MEN1KMT2ANPC1
SCHEMBL8615244 0.83 CYP3A4 (0.56) KDM4ESMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL8617743 0.83 CYP3A4 (0.65) KDM4ESMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL8619733 0.82 DHODH (0.58) KDM4ESMN1; SMN2MEN1KMT2ANPC1
SCHEMBL8615354 0.82 CYP3A4 (0.65) KDM4ESMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL8614305 0.82 GAA (0.51) KDM4EMEN1KMT2AALDH1A1LMNA
Hydrochloric Acid SCHEMBL8620745 0.82 CYP3A4 (0.64) KDM4ESMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL8614318 0.82 ACACA (0.43) KDM4ESMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL8615123 0.81 DHODH (0.59) KDM4ESMN1; SMN2MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0726254-B1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS (JP) 1998-05-06 EP disclosed
US-5627193-A MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION MITSUI TOATSU CHEMICALS, INC. (JP) 1997-05-06 US disclosed
EP-0726254-A1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-08-14 EP disclosed